Biotech grants in Ireland

Funds research into new tools and conversion routes that turn low-value forest residues into bio-based chemicals, materials or products beyond bioenergy.

Open

Funds Ireland innovation teams building equity and growth support for startups from proof to commercialization.

Open

Supports Ireland researchers with structured pathways in co-funding for applied PhD hires in companies, from planning to deployment.

Open

Provides early-stage technology teams with support for product, capability, and milestone growth planning.

Open

Provides Irish enterprises planning support for innovation programmes that strengthen global markets.

Between cycles

Covers 80% of a €3,000 cyber security review for Irish businesses.

Between cycles

Supports Irish small businesses with innovation vouchers for feasibility studies prototypes audits or new product and service development.

Between cycles

Administers Ireland innovation tax credit, allowing qualifying companies to claim expanded relief for innovation activity.

Between cycles

Offers founders over €40,000 in equity-free support, plus a €15,000 stipend in phase two.

Between cycles

Grants Irish businesses up to €150,000 to develop and test new market entry strategies.

Between cycles

Funds third-level researchers up to €100,000 to move research toward market readiness.

Between cycles

Pays for up to €1,750 toward ten sessions with an experienced business mentor.

Between cycles

Grants Irish SMEs up to €35,000 to hire an external strategy consultant.

Between cycles

Supports UCD researchers launching commercial ventures based on university intellectual property.

Between cycles

Funds venture managers for Irish-focused seed and later-stage funds through Enterprise Ireland-backed capital commitments.

Open

Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.

Open

Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.

Open

Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.

Open

Funds a consortium to build a new EIT Label-certified micro-credentials programme teaching entrepreneurship and innovation to healthcare students.

Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.

Pays $10,000 for a genuinely new way to verify cleanliness in under 30 minutes.

Open

Funds four centres to work out how cancer actually spreads — each on one theme, through two or three interlocking basic research projects.

Open

Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.

Open

Funds research teams building low-cost, simplified pathogen-sequencing workflows that bring the cost of sequencing a sample down to about US$1-10 for use in low- and middle-income countries.